Multivariate analysis
| Variable . | RL . | RR . | CI (95%) . | P . |
|---|---|---|---|---|
| Overall survival9-150 | ||||
| Response to therapy | Complete | 0.089 | 0.011 -0.716 | .026 |
| Involvement of nonhematopoietic sites | Absent | 4.676 | 0.962 -22.74 | .05 |
| Failure-free survival9-151 | ||||
| Response to therapy | ||||
| Noncomplete | Complete | 3.935 | 1.202 -12.877 | .023 |
| Involvement of nonhematopoietic sites | Absent | 4.901 | 1.001 -23.895 | .049 |
| Probability to obtain CR | ||||
| Bone marrow involvement | Absent | 0.172 | 0.031 -0.951 | .043 |
| Variable . | RL . | RR . | CI (95%) . | P . |
|---|---|---|---|---|
| Overall survival9-150 | ||||
| Response to therapy | Complete | 0.089 | 0.011 -0.716 | .026 |
| Involvement of nonhematopoietic sites | Absent | 4.676 | 0.962 -22.74 | .05 |
| Failure-free survival9-151 | ||||
| Response to therapy | ||||
| Noncomplete | Complete | 3.935 | 1.202 -12.877 | .023 |
| Involvement of nonhematopoietic sites | Absent | 4.901 | 1.001 -23.895 | .049 |
| Probability to obtain CR | ||||
| Bone marrow involvement | Absent | 0.172 | 0.031 -0.951 | .043 |